# Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation

> **NCT00410150** · PHASE2 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 42 (actual)

## Conditions studied

- Status Asthmaticus

## Interventions

- **DRUG:** Helium-oxygen-driven albuterol nebulizer
- **DRUG:** Oxygen

## Key facts

- **NCT ID:** NCT00410150
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** Study was stopped after interim analysis and slow enrollment.
- **Last updated:** 2010-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410150, "Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00410150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*